Integrated Model of Metabolism and Autoimmune Response in β-Cell Death and Progression to Type 1 Diabetes

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Marinković, Tijana ^a   Sysi Aho, Marko ^a   Orešič, Matej ^a  

^a VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; REACTIVE OXYGEN METABOLITE;

ARTICLE; AUTOIMMUNITY; CELL DEATH; CELL DEGENERATION; CELL DESTRUCTION; CELL LOSS; DISEASE COURSE; DISORDERS OF CARBOHYDRATE METABOLISM; INSULIN DEPENDENT DIABETES MELLITUS; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; PANCREAS ISLET BETA CELL;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; CELL DEATH; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; HUMANS; INSULIN-SECRETING CELLS; LONGITUDINAL STUDIES; MICE; MODELS, IMMUNOLOGICAL;

EID: 84871343233     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051909     Document Type: Article

References (24)

1. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G, (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 373: 2027-2033.
2. Achenbach P, Bonifacio E, Koczwara K, Ziegler A-G, (2005) Natural history of type 1 diabetes. Diabetes 54: S25-31.
3. Kimpimaki T, Kulmala P, Savola K, Kupila A, Korhonen S, et al. (2002) Natural history of {beta}-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 87: 4572-4579.
4. Burnet M, (1959) Auto-immune disease. II. Pathology of the immune response. Br Med J 2: 720-725.
5. Burnet M, (1959) Auto-immune disease. I. Modern immunological concepts. Br Med J 2: 645-650.
6. Yoles E, Hauben E, Palgi O, Agranov E, Gothilf A, et al. (2001) Protective autoimmunity is a physiological response to CNS trauma. J Neurosci 21: 3740-3748.
7. Schwartz M, Shaked I, Fisher J, Mizrahi T, Schori H, (2003) Protective autoimmunity against the enemy within: fighting glutamate toxicity. Trends Neurosci 26: 297-302.
8. Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, et al. (1999) Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5: 49-55.
9. Oresic M, Simell S, Sysi-Aho M, Nanto-Salonen K, Seppanen-Laakso T, et al. (2008) Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med 205: 2975-2984.
10. Sysi-Aho M, Ermolov A, Gopalacharyulu PV, Tripathi A, Seppanen-Laakso T, et al. (2011) Metabolic regulation in progression to autoimmune diabetes. PLoS Comput Biol 7: e1002257.
11. Nerup J, Mandrup-Poulsen T, Helqvist S, Andersen HU, Pociot F, et al. (1994) On the pathogenesis of IDDM. Diabetologia 37Suppl 2: S82-89.
12. Nerup J, Mandrup-Poulsen T, Molvig J, Helqvist S, Wogensen L, et al. (1988) Mechanisms of pancreatic beta-cell destruction in type I diabetes. Diabetes Care 11Suppl 1: 16-23.
13. Freiesleben De Blasio B, Bak P, Pociot F, Karlsen AE, Nerup J, (1999) Onset of type 1 diabetes: a dynamical instability. Diabetes 48: 1677-1685.
14. Nevo U, Golding I, Neumann AU, Schwartz M, Akselrod S, (2004) Autoimmunity as an immune defense against degenerative processes: a primary mathematical model illustrating the bright side of autoimmunity. J Theor Biol 227: 583-592.
15. Nevo U, Kipnis J, Golding I, Shaked I, Neumann A, et al. (2003) Autoimmunity as a special case of immunity: removing threats from within. Trends Mol Med 9: 88-93.
16. Matzinger P, (1998) An innate sense of danger. Semin Immunol 10: 399-415.
17. Knip M, Veijola R, Virtanen SM, Hyöty H, Vaarala O, et al. (2005) Environmental triggers and determinants of type 1 diabetes. Diabetes 54: S125-136.
18. Topp B, Promislow K, deVries G, Miura RM, Finegood DT, (2000) A model of beta-cell mass, insulin, and glucose kinetics: pathways to diabetes. J Theor Biol 206: 605-619.
19. Maree AF, Kublik R, Finegood DT, Edelstein-Keshet L, (2006) Modelling the onset of Type 1 diabetes: can impaired macrophage phagocytosis make the difference between health and disease? Philos Transact A Math Phys Eng Sci 364: 1267-1282.
20. Nelder JA, Mead R, (1965) A simplex method for function minimization. Comput J 7: 308-313.
21. Rapoport MJ, Jaramillo A, Zipris D, Lazarus AH, Serreze DV, et al. (1993) Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 178: 87-99.
22. Mehta D, (2005) Lysophosphatidylcholine: an enigmatic lysolipid. Am J Physiol Lung Cell Mol Physiol 289: L174-175.
23. Ott M, Gogvadze V, Orrenius S, Zhivotovsky B, (2007) Mitochondria, oxidative stress and cell death. Apoptosis 12: 913-922.
24. Selivanov VA, Votyakova TV, Pivtoraiko VN, Zeak J, Sukhomlin T, et al. (2011) Reactive oxygen species production by forward and reverse electron fluxes in the mitochondrial respiratory chain. PLoS Comput Biol 7: e1001115.